Stimwave launches StimQ Peripheral Nerve Stimulator (PNS) System for the relief of severe intractable chronic pain of peripheral origin.
Stimwave, LLC, a leading innovator in wireless medical device technology and independent research institute, announced that it has begun to market the StimQ Peripheral Nerve Stimulator (PNS) System for the relief of severe intractable chronic pain of peripheral origin.
The StimQ PNS System, the world�s first wireless, fully-programmable PNS (peripheral nerve stimulator) neuromodulation device, received FDA 510k clearance this month. It presents a potentially life-changing technological breakthrough for the 400 million people worldwide who suffer from severe intractable chronic pain that do not want to rely on invasive surgical procedures or ongoing opioid (narcotic) treatment for pain management.
Comment: The technology uses a miniature device�which is less than 5% of the size of other standard implanted options�that delivers small pulses of energy, in a fully-selectable manner, to electrodes placed at a peripheral nerve. The implant is powered by a small, flexible and comfortable wearable external fabric patch unit.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.